Motility and tumor infiltration are key aspects of invariant natural killer T cell anti-tumor function

Nat Commun. 2024 Feb 9;15(1):1213. doi: 10.1038/s41467-024-45208-z.

Abstract

Dysfunction of invariant natural killer T (iNKT) cells contributes to immune resistance of tumors. Most mechanistic studies focus on their static functional status before or after activation, not considering motility as an important characteristic for antigen scanning and thus anti-tumor capability. Here we show via intravital imaging, that impaired motility of iNKT cells and their exclusion from tumors both contribute to the diminished anti-tumor iNKT cell response. Mechanistically, CD1d, expressed on macrophages, interferes with tumor infiltration of iNKT cells and iNKT-DC interactions but does not influence their intratumoral motility. VCAM1, expressed by cancer cells, restricts iNKT cell motility and inhibits their antigen scanning and activation by DCs via reducing CDC42 expression. Blocking VCAM1-CD49d signaling improves motility and activation of intratumoral iNKT cells, and consequently augments their anti-tumor function. Interference with macrophage-iNKT cell interactions further enhances the anti-tumor capability of iNKT cells. Thus, our findings provide a direction to enhance the efficacy of iNKT cell-based immunotherapy via motility regulation.

MeSH terms

  • Antigens, CD1d / metabolism
  • Humans
  • Immunotherapy / methods
  • Lymphocyte Activation
  • Macrophages / metabolism
  • Natural Killer T-Cells*
  • Neoplasms* / metabolism
  • Neoplasms* / therapy

Substances

  • Antigens, CD1d